DAILY ADMINISTRATION OF SWARNAMRITAPRASHANA IN INFANTS

EFFECT OF DAILY ADMINISTRATION OF SWARNAMRITAPRASHANA ON GROWTH AND DEVELOPMENT IN INFANTS (0 TO 6 MONTHS)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025006

Enrollment

Registered

2020-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Swarnamritaprashana: The ingredients of swarnamritaprashana include well known nootropic herbs of Ayurveda namely mandukaparni Centella asiatica Linn shankhapushpi Convolvulus pl

Eligibility

Inclusion criteria

Inclusion criteria: 1 Healthy infants having weight between 2500gm to 3500gm irrespective of gender religion and socio-economic status will be included in the study 2 Those parents who are consciously willing to participate their children in the study and ready to sign the informed assent form

Exclusion criteria

Exclusion criteria: 1 Any health reason of the baby requiring continuous monitoring and medical care like Intra uterine growth retardation Prematurity Asphyxia Sepsis 2 Infants suffering from Congenital anomalies 3 Infants suffering from any Acute Systemic Illness

Design outcomes

Primary

Measure	Time frame
improvemet in growth and developmentTimepoint: Growth assessment at first second third fourth fifth sixth months developmental assessment at 3rd and 6th month	—

Secondary

Measure	Time frame
improvement in health statusTimepoint: health assessment at first second third fourth fifth sixth months	—

Countries

India

Contacts

Public ContactDr VIJAYALAXMI MALLANNVAR

ASSOCIATE PROFESSOR

abittu@gmail.com9480624829

Outcome results